Patients with Long-Term Survival in Malignant Gliomas after Photodynamic Therapy
Authors:
- 1 October 2024
- journal article
- research article
- Published by Springer Nature in Neuroscience and Behavioral Physiology
- Vol. 54 (8) , 1215-1221
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- 362P Influence of the expression of ABCG2 transporters on the results of photodynamic therapy in malignant gliomasAnnals of Oncology, 2021
- 377P Long-term survival following photodynamic therapy for malignant glioma depending on MGMT statusAnnals of Oncology, 2020
- Improved 3-year survival rates for glioblastoma multiforme are associated with trends in treatment: analysis of the national cancer database from 2004 to 2013Journal of Neuro-Oncology, 2020
- Trends and patterns of incidence of diffuse glioma in adults in the United States, 1973‐2014Cancer Medicine, 2018
- Molecular profiling of short-term and long-term surviving patients identifies CD34 mRNA level as prognostic for glioblastoma survivalJournal of Neuro-Oncology, 2018
- Long-term survivors of glioblastoma: a closer lookJournal of Neuro-Oncology, 2017
- Expression and function of ABCG2 and XIAP in glioblastomasJournal of Neuro-Oncology, 2017
- The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summaryActa Neuropathologica, 2016
- ATRX and IDH1-R132H immunohistochemistry with subsequent copy number analysis and IDH sequencing as a basis for an “integrated” diagnostic approach for adult astrocytoma, oligodendroglioma and glioblastomaActa Neuropathologica, 2014
- Molecular characterization of long-term survivors of glioblastoma using genome- and transcriptome-wide profilingInternational Journal of Cancer, 2014